Insiders · TPST

TPST insider transactions

Tempest Therapeutics Inc. (TPST) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for TPST

• 28d
  SEC Form 4 filed by Trojanowski Justin

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 28d
  SEC Form 4 filed by Maestas Nicholas

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 36d
  SEC Form 4 filed by Angel Matthew

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 83d
  SEC Form 4 filed by CEO and President Angel Matthew

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 83d
  New insider Angel Matthew claimed ownership of 8,268,495 shares (SEC Form 3)

  3 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 92d
  SEC Form 4 filed by Director Pellizzari Christine A

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 92d
  SEC Form 4 filed by Director Nichol Geoffrey

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 92d
  SEC Form 4 filed by Director Raab Michael

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 92d
  SEC Form 4 filed by Director Simantov Ronit

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 479d
  SEC Form 4 filed by President and CEO Brady Stephen R

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 479d
  SEC Form 4 filed by Chief Financial Officer Maestas Nicholas

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 479d
  SEC Form 4 filed by Corporate Controller Trojanowski Justin

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 479d
  SEC Form 4 filed by Chief Medical Officer Whiting Samuel

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 626d
  Large owner Versant Venture Capital Vi, L.P. sold $967,033 worth of shares (787,999 units at $1.23) (SEC Form 4)

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 661d
  President and CEO Brady Stephen R bought $73,850 worth of shares (35,000 units at $2.11), increasing direct ownership by 308% to 46,376 units (SEC Form 4)

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 666d
  Chief Medical Officer Whiting Samuel bought $9,951 worth of shares (4,672 units at $2.13), increasing direct ownership by 95% to 9,573 units (SEC Form 4)

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 667d
  Corporate Controller Trojanowski Justin bought $16,200 worth of shares (7,500 units at $2.16), increasing direct ownership by 51% to 22,168 units (SEC Form 4)

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 685d
  SEC Form 4 filed by Director Nichol Geoffrey

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 685d
  SEC Form 4 filed by Director Raab Michael

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 685d
  SEC Form 4 filed by Director Simantov Ronit

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 685d
  SEC Form 4 filed by Director Pellizzari Christine A

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 846d
  SEC Form 4 filed by Brady Stephen R

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 846d
  SEC Form 4 filed by Whiting Samuel

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 846d
  SEC Form 4 filed by Trojanowski Justin

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 846d
  SEC Form 4 filed by Maestas Nicholas

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 930d
  SEC Form 4 filed by Brady Stephen R

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 930d
  SEC Form 4 filed by Trojanowski Justin

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 930d
  SEC Form 4 filed by Whiting Samuel

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 930d
  SEC Form 4 filed by Maestas Nicholas

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1045d
  SEC Form 4 filed by Raab Michael

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1045d
  SEC Form 4 filed by Nichol Geoffrey

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1045d
  SEC Form 4 filed by Pellizzari Christine A

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1045d
  SEC Form 4 filed by Simantov Ronit

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1211d
  SEC Form 4 filed by Whiting Samuel

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1211d
  SEC Form 4 filed by Dubensky Thomas W.

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1211d
  SEC Form 4 filed by Brady Stephen R

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1211d
  SEC Form 4 filed by Maestas Nicholas

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1211d
  SEC Form 4 filed by Trojanowski Justin

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1304d
  SEC Form 4 filed by Trojanowski Justin

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1304d
  SEC Form 3 filed by new insider Trojanowski Justin

  3 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1408d
  SEC Form 4 filed by Lorenzo Pierre

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1408d
  SEC Form 4 filed by Maestas Nicholas

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1408d
  SEC Form 4 filed by Whiting Samuel

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1408d
  SEC Form 4 filed by Dubensky Thomas W.

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1408d
  SEC Form 4 filed by Brady Stephen R

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1408d
  SEC Form 4 filed by Pellizzari Christine A

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1408d
  SEC Form 4 filed by Nichol Geoffrey

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1408d
  SEC Form 4 filed by Woiwode Thomas

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1408d
  SEC Form 4 filed by Simantov Ronit

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1408d
  SEC Form 4 filed by Raab Michael

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1458d
  SEC Form 4: Woiwode Thomas bought $5,000,000 worth of shares (2,118,644 units at $2.36)

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1458d
  SEC Form 4 filed by Versant Venture Capital Vi, L.P.

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1458d
  SEC Form 3: New insider Versant Vantage Ii, L.P. claimed ownership of 2,118,644 shares

  3 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1570d
  SEC Form 4: Dubensky Thomas W. bought $9,560 worth of shares (2,000 units at $4.78), increasing direct ownership by 2% to 113,343 units

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1571d
  SEC Form 4: Whiting Samuel bought $8,168 worth of shares (1,700 units at $4.80), increasing direct ownership by 846% to 1,901 units

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1571d
  SEC Form 3: New insider Rock Springs Capital Management Lp claimed ownership of 823,654 shares

  3 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1575d
  SEC Form 4 filed by Lorenzo Pierre

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1575d
  SEC Form 4 filed by Maestas Nicholas

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1575d
  SEC Form 4 filed by Whiting Samuel

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
• 1575d
  SEC Form 4 filed by Brady Stephen R

  4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)